Eagle Health Investments’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-59,091
Closed -$28.7M – 29
2022
Q3
$28.7M Sell
59,091
-21,100
-26% -$10.3M 6.58% 5
2022
Q2
$37.5M Buy
80,191
+2,300
+3% +$1.02M 8.75% 2
2022
Q1
$33.9M Sell
77,891
-730
-0.9% -$305K 8.35% 1
2021
Q4
$36.5M Buy
78,621
+10,100
+15% +$4.47M 8.89% 1
2021
Q3
$26.7M Buy
68,521
+20,800
+44% +$8.83M 8.46% 2
2021
Q2
$21.1M Buy
47,721
+2,800
+6% +$1.22M 7.25% 2
2021
Q1
$18.8M Buy
44,921
+13,759
+44% +$5.49M 7.39% 3
2020
Q4
$12.8M Buy
+31,162
New +$13M 8.18% 2

Other funds holding HUM

Eagle Health Investments's HUM Position: Q4 2022 in Review

Eagle Health Investments sold out of Humana (HUM) in Q4 2022, closing a stake of 59,091 shares — an estimated $28.7M sold.

Eagle Health Investments first reported a position in HUM in Q4 2020 and held it in 8 quarters. The position peaked at $37.5M in Q2 2022. 1,077 funds tracked by Wall St. Rank hold HUM as of Q4 2022.

  • Eagle Health Investments reported no remaining Humana position as of Q4 2022 after selling out during the quarter.
  • Eagle Health Investments sold 59,091 Humana shares in Q4 2022, an estimated $28.7M.
  • Eagle Health Investments first reported a position in Humana in Q4 2020 and held it in 8 quarters.
  • Eagle Health Investments's Humana position peaked at $37.5M in Q2 2022.
  • 1,077 funds tracked by Wall St. Rank held Humana as of Q4 2022.

Based on Eagle Health Investments's 13F filing for Q4 2022, filed 13 Feb 2023.